Atlas Trials

Vaccines

39 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Vaccines

RecordFirmDate
Phase Ⅲ, Clinical Trial to Compare an Inactivated Quadrivalent Influenza Vaccine and a Licensed Vaccine in Chile (NCT05494047)Pontificia Universidad Catolica de Chile2022-07-14
Korea Comirnaty Post-marketing Surveillance (NCT05032976)Pfizer2022-03-18
Informing the Population of Their Level of Protection Against COVID-19 in Monaco: a Prospective Study (MonaVacc) (NCT05084950)Centre Scientifique de Monaco2021-07-01
Trial of Tolerability, Safety and Immunogenicity of the Flu-M Vaccine in Children Between 6 Months and 9 Years Old (NCT05470582)St. Petersburg Research Institute of Vaccines and Sera2021-02-16
Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients. (NCT04388033)Second Affiliated Hospital, Zhejiang University, School of Medicine2020-12-01
Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in Adults (NCT04651790)Pontificia Universidad Catolica de Chile2020-11-27
Trial of Tolerability, Reactogenicity, Safety and Immunogenicity of Flu-M [Inactivated Split Influenza Vaccine] in Pregnant Women (NCT05457894)St. Petersburg Research Institute of Vaccines and Sera2020-01-23
Safety and Reactogenicity Trial of Vaccine for the Prevention of Infections Caused by Haemophilus Influenzae Type b (NCT05401305)St. Petersburg Research Institute of Vaccines and Sera2020-01-14
Study To Describe The Safety Of 13-valent Pneumococcal Conjugate Vaccine In Children 6 To 17 Years Of Age In India (NCT03777865)Pfizer2018-12-14
Patient Portal - Flu Reminder Recall (NCT03666026)University of California, Los Angeles2018-10-02
Venezuelan Equine Encephalitis Monovalent Virus-Like Particle Vaccine (NCT03776994)SRI International2018-07-17
Study To Describe The Safety, Tolerability, And Immunogenicity Of 13- Valent Pneumococcal Conjugate Vaccine Formulated In Multidose Vials When Given With Routine Pediatric Vaccines In Healthy Infants In India (NCT03548337)Pfizer2018-05-31
Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018) (NCT03392207)Butantan Institute2018-04-23
HPV Centralized R/R RCT #2 - New York State (NCT03294551)University of California, Los Angeles2017-10-27
Centralized Reminder Recall - Flu RCT2 (NCT03294473)University of California, Los Angeles2017-10-18
Immunization Services Model for Adult Rate Improvement (NCT02609035)Pharmacy Quality Alliance2016-03-31
Natural Dendritic Cells for Immunotherapy of Chemo-naive Metastatic Castration-resistant Prostate Cancer Patients (NCT02692976)Radboud University Medical Center2015-09-01
A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet® With or Without ID Derma Vax™ Electroporation Followed by IM MVA Boosting in Healthy Volunteers in Tanzania and Mozambique (NCT01697007)Muhimbili University of Health and Allied Sciences2012-11-01
A Study to Assess the Safety and Tolerability of Different Doses of PF-05402536 and PF-06413367 in Healthy Adult Smokers. (NCT01672645)Pfizer2012-06-01
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17 (NCT01461993)Pfizer2011-09-28
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age (NCT01461980)Pfizer2011-09-28
Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered to Infants in Taiwan (NCT00688870)Wyeth is now a wholly owned subsidiary of Pfizer2008-06-05
Experimental Vaccine for Plasmodium Falciparum Malaria (NCT00340431)National Institute of Allergy and Infectious Diseases (NIAID)2004-06-09

Track Vaccines automatically

Every clearance here is in the API, with alerts when new ones post.